首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4995043篇
  免费   408002篇
  国内免费   15968篇
耳鼻咽喉   71612篇
儿科学   158448篇
妇产科学   133779篇
基础医学   747321篇
口腔科学   143297篇
临床医学   455452篇
内科学   911971篇
皮肤病学   116890篇
神经病学   421887篇
特种医学   199387篇
外国民族医学   1270篇
外科学   754555篇
综合类   147560篇
现状与发展   23篇
一般理论   2884篇
预防医学   420917篇
眼科学   119836篇
药学   357715篇
  23篇
中国医学   12831篇
肿瘤学   241355篇
  2021年   56379篇
  2019年   59029篇
  2018年   75151篇
  2017年   57154篇
  2016年   63846篇
  2015年   76461篇
  2014年   111415篇
  2013年   176925篇
  2012年   137693篇
  2011年   144444篇
  2010年   129144篇
  2009年   130175篇
  2008年   131469篇
  2007年   140477篇
  2006年   148776篇
  2005年   143373篇
  2004年   144376篇
  2003年   134269篇
  2002年   124763篇
  2001年   190682篇
  2000年   188757篇
  1999年   170754篇
  1998年   75984篇
  1997年   71117篇
  1996年   69000篇
  1995年   64794篇
  1994年   58876篇
  1993年   54627篇
  1992年   129662篇
  1991年   124669篇
  1990年   119728篇
  1989年   116402篇
  1988年   108252篇
  1987年   106616篇
  1986年   101400篇
  1985年   98984篇
  1984年   80829篇
  1983年   71370篇
  1982年   53424篇
  1981年   49330篇
  1980年   46405篇
  1979年   73398篇
  1978年   56993篇
  1977年   49703篇
  1976年   46460篇
  1975年   46662篇
  1974年   54031篇
  1973年   51898篇
  1972年   48610篇
  1971年   44982篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
64.
Major depressive disorder and other neuropsychiatric disorders are often managed with long-term use of antidepressant medication. Fluoxetine, an SSRI antidepressant, is widely used as a first-line treatment for neuropsychiatric disorders. However, fluoxetine has also been shown to increase the risk of metabolic diseases such as non-alcoholic fatty liver disease. Fluoxetine has been shown to increase hepatic lipid accumulation in vivo and in vitro. In addition, fluoxetine has been shown to alter the production of prostaglandins which have also been implicated in the development of non-alcoholic fatty liver disease. The goal of this study was to assess the effect of fluoxetine exposure on the prostaglandin biosynthetic pathway and lipid accumulation in a hepatic cell line (H4-II-E-C3 cells). Fluoxetine treatment increased mRNA expression of prostaglandin biosynthetic enzymes (Ptgs1, Ptgs2, and Ptgds), PPAR gamma (Pparg), and PPAR gamma downstream targets involved in fatty acid uptake (Cd36, Fatp2, and Fatp5) as well as production of 15-deoxy-Δ12,14PGJ2 a PPAR gamma ligand. The effects of fluoxetine to induce lipid accumulation were attenuated with a PTGS1 specific inhibitor (SC-560), whereas inhibition of PTGS2 had no effect. Moreover, SC-560 attenuated 15-deoxy-Δ12,14PGJ2 production and expression of PPAR gamma downstream target genes. Taken together these results suggest that fluoxetine-induced lipid abnormalities appear to be mediated via PTGS1 and its downstream product 15d-PGJ2 and suggest a novel therapeutic target to prevent some of the adverse effects of fluoxetine treatment.  相似文献   
65.
Cognitive Therapy and Research - Despite interest in psychological inflexibility as a marker of suicide risk, no measure of psychological inflexibility specific to SI exists. The present study...  相似文献   
66.
67.
68.
69.
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus.  相似文献   
70.
Heart Failure Reviews - The nitric oxide (NO)–guanylate cyclase (GC)–cyclic guanosine monophosphate (cGMP) pathway plays an important role in cardiovascular, pulmonary and renal...  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号